Breathe Well Live Well
Daily Beast |
Is Advair, the Ultra-Popular Asthma Drug, Really Safe?
Daily Beast The asthma drug has generated more than $80 billion in global revenues for its maker, GlaxoSmithKline, since its U.S. approval in 2000. With its distinctive purple inhaler, Advair has helped legions of asthma sufferers achieve control of their symptoms. |
View full post on asthma – Google News
|
ProPublica: Safety questions over GSK's Advair linger after years on the …
FiercePharma Recent research suggests that a significant percentage of asthma patients begin using Advair inappropriately, the watchdog says, and that can trigger the "risk of asthma-related death" described on the med's label. And while the FDA in 2010 required … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Treatment A: Fp MDPI; Drug: Treatment B: FS MDPI; Drug: Treatment C Flovent; Drug: Treatment D: Advair
Sponsor: Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Condition: Asthma
Interventions: Drug: MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Advair (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate); Drug: Placebo
Sponsors: Mylan Inc.; Mylan Pharma UK Ltd.
Not yet recruiting – verified September 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
NerdWallet (blog) |
Saving on Asthma Medications: Albuterol, Advair, Flovent and Singulair
NerdWallet (blog) Saving money on the most commonly sought medications for asthma—albuterol, Advair, Flovent and Singulair—is important, especially for sufferers of a lifelong condition and those with tight budgets. After all, many patients cite cost as a reason for … |
View full post on asthma – Google News
The West Australian |
Prospect of generic asthma drug Advair hits Glaxo
Philly.com GlaxoSmithKline P.L.C.'s top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue, but generic competition got a bit closer to reality this week. Advair is delivered to patients through an inhaler … Mylan shares jump after FDA lays out guidelines for asthma generic FDA Offers Guidance for Advair Knockoffs Glaxo May Face Generic Advair Sooner Than Expected |
View full post on asthma – Google News
Yahoo!7 News |
FDA issues generic guidance on GSK's top-selling asthma drug, Advair
Philly.com (blog) PhillyPharma. FDA issues generic guidance on GSK's top-selling asthma drug, Advair. GlaxoSmithKline's top-selling drug by far is the asthma medication Advair, which accounts for about 20 percent of company revenue. Generic competition got a bit closer … GlaxoSmithKline Shares Fall After Advair Setback Glaxo Declines as FDA Clears Path for Advair Rivals New FDA guidance threatens GlaxoSmithKline's Advair |
View full post on asthma – Google News
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: QVA149; Drug: fluticasone/salmeterol
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting – verified April 2013
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
 DrugWatch.com |
Investigation Shows Advair Inappropriately Used for Mild Asthma
DrugWatch.com GlaxoSmithKline's Advair has been prescribed for millions of asthma patients — including children — despite medical records and independent doctors indicating it isn't the correct treatment. The drug “has been massively overused and often … |
View full post on asthma – Google News
|
Asthma preventive drugs market led by GlaxoSmithKline's Advair
The Pharma Letter Asthma is a respiratory condition in which the airways become inflamed and constrict, usually in response to one or more environmental triggers. As a serious and potentially fatal condition if left untreated, asthma can be managed by avoiding triggers … |
View full post on asthma – Google News